3

FORM 3 SUBMISSION

Company: KalVista Pharmaceuticals, Inc.
Filed: September 10, 2018
Period of Report: September 10, 2018
Accession Number: 0001209191-18-050263

View Document ↗ View on SEC.gov ↗